XML 38 R26.htm IDEA: XBRL DOCUMENT v3.7.0.1

Stockholders' Equity (Tables)

12 Months Ended

Mar. 31, 2017

Stockholders' Equity Note [Abstract]

Schedule of Nonvested Share Activity

A summary of the Company’s restricted stock issued to employees, directors and consultants with a right of repurchase of unlapsed or unvested shares is as follows:

		Weighted-Average Remaining
		Vesting Life						Weighted-Average Per Share
											Grant Date
		Shares			(In Years)			Intrinsic Value			Fair Value
Unvested or unlapsed shares at April 1, 2015			12,222			0.3		$	0.50		$	4.10
Granted			-			-			-			-
Vested/lapsed			(12,222)			-			-			-
Forfeited			-			-			-			-
Unvested or unlapsed shares at March 31, 2016 and 2017			-			-			-			-

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The following table presents details of the assumptions used to calculate the weighted-average grant date fair value of common stock options granted by the Company:

		Years Ended
		March 31,				March 31,
		2017				2016
Expected term (in years)			4.6 – 6.0				6.0
Expected volatility			126.42 -136.04	%			133	%
Risk-free interest rate			0.75 – 1.06	%			1.31 – 1.94	%
Expected dividends		$	-			$	-
Weighted-average grant date fair value per share		$	3.92			$	4.75

Stock Option Transactions Under Stock Option Plans

Stock option activity is summarized below:

					Weighted-Average			Weighted-Average			Weighted-Average
					Per Share			Remaining Life			Per Share
		Option Shares			Exercise Price			(Years)			Intrinsic Value
Balance, April 1, 2015			776,500		$	4.69			7.40		$	1.50
Granted			374,150			5.97			-			-
Cancelled/expired			(86,500)			2.63			-			-
Exercised			-			-			-			-
Balance, March 31, 2016			1,064,150		$	4.27			7.94		$	2.27
Granted			149,200			4.78			-			-
Cancelled/expired			(48,000)			6.75			-			-
Exercised			-			-			-			-
Balance, March 31, 2017			1,165,350		$	4.24			6.64		$	4.86
Vested and exercisable, March 31, 2017			1,028,043		$	4.07			6.36		$	5.25

Summary of Restricted Stock Award

The following table summarizes the restricted stock award in the ACO Plan:

					Weighted-Average			Weighted-Average
					Remaining			Per Share Fair
					Vesting Life			Value
		Shares			(Years)
Balance, April 1, 2015			3,752,000			0.8		$	0.03
Granted			184,000			-			0.77
Released			(183,996)			-			0.03
Balance, March 31, 2016			3,752,004			-			0.07
Granted			-			-			-
Released			(32,000)			-			-
Balance, March 31, 2017			3,720,004			-		$	0.07
Vested and exercisable, end of year			3,720,004			-		$	0.07

Total Unrecognized Compensation Costs Related To Non-Vested Stock-Based Compensation Arrangements

As of March 31, 2017, total unrecognized compensation costs related to non-vested stock-based compensation arrangements granted under the Company’s 2010, 2013 and 2015 Equity Plans, are as follows:

Common stock options $ 435,739

Summary of Stock Based Compensation Expense Related To Restricted Stock and Option Awards

Stock-based compensation expense related to common stock and common stock option awards is recognized over their respective vesting periods and was included in the accompanying consolidated statement of operations as follows:

		For The Years Ended
		March 31,
		2017			2016
Stock-based compensation expense:
Cost of services		$	4,906		$	4,959
General and administrative			1,101,548			1,099,017
		$	1,106,454		$	1,103,976

Warrants Outstanding

Warrants consisted of the following:

		Weighted-Average
		Per Share			Number of
		Intrinsic Value			Warrants
Outstanding at April 1, 2015		$	0.46			914,500
Granted			-			1,676,666
Exercised			-			(500,000)
Cancelled			-			-
Outstanding at March 31, 2016			3.12			2,091,166
Granted			-			29,000
Exercised			4.87			(150,000)
Cancelled			-			-
Outstanding at March 31, 2017		$	4.68			1,970,166

						Weighted						Weighted
						Average						Average
Exercise Price Per			Warrants			Remaining			Warrants			Exercise Price Per
Share			Outstanding			Contractual Life			Exercisable			Share
	$4.00-$5.00			188,500			0.85			169,500		$	4.47
	$9.00-$10.00			1,781,666			3.54			1,781,666			9.37
	$1.15-$10.00			1,970,166			3.28			1,951,166		$	8.90

Amount of Shares of Common Stock Reserved

The amount of shares of common stock reserved for these purposes is as follows at March 31, 2017:

Common stock issued and outstanding			6,033,518
Warrants outstanding			1,970,166
Stock options outstanding			1,165,350
Shares issuable upon conversion of convertible note			499,000
Preferred stock			1,666,666
			11,334,700

X

- Definition

Schedule Of Common Stock Reserved For Future Issuance [Table Text Block]

+ References

No definition available.

+ Details

Name:	ameh_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock
Namespace Prefix:	ameh_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested restricted stock shares.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the amount of total share-based compensation cost, including the amounts attributable to each share-based compensation plan and any related tax benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68057994&loc=d3e25284-112666

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the total compensation cost related to nonvested awards not yet recognized and the weighted-average period over which it is expected to be recognized.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration